According to Amylyx Pharmaceuticals's latest financial reports the company's current revenue (TTM ) is -ยฃ0.5 Million. In 2024 the company made a revenue of ยฃ69.62 Million a decrease over the revenue in the year 2023 that were of ยฃ0.29 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.